Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the …

…,M Hoenigl,HE Jensen, K Lagrou,RE刘易斯… - The Lancet infectious …, 2019 - Elsevier
Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality.
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical …

Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses …

…, TJ Walsh,A Warris, LJ Wheat, PLWhite… - Clinical Infectious …, 2020 - academic.oup.com
Background Invasive fungal diseases (IFDs) remain important causes of morbidity and
mortality. The consensus definitions of the Infectious Diseases Group of the European …

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

…,JF Meis,L Ostrosky-Zeichner, PLWhite… - The Lancet Infectious …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway
epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary …

A national strategy to diagnose coronavirus disease 2019–associated invasive fungal disease in the intensive care unit

plWhite, R Dhillon, A Cordey, H Hughes… - Clinical Infectious …, 2021 - academic.oup.com
Background Fungal coinfection is a recognized complication of respiratory virus infections,
increasing morbidity and mortality, but can be readily treated if diagnosed early. An …

Aspergillus PCR: one step closer to standardization

plWhite, S Bretagne, L Klingspor… - Journal of clinical …, 2010 - Am Soc Microbiol
PCR has been used as an aid in the diagnosis of invasive aspergillosis for almost 2
decades. A lack of standardization has limited both its acceptance as a diagnostic tool and …

在常规临床中,对血液学患者中侵袭性曲霉病检测的全血聚合酶链反应测定法的进化和评估……

plWhite, CJ Linton, MD Perry… - Clinical infectious …, 2006 - academic.oup.com
Background . Invasive aspergillosis (IA) is associated with high mortality. Successful
outcome with treatment is linked to early diagnosis. The utility of classic diagnostic methods, …

Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis

…,PE Verweij,PLWhite… - European …, 2020 - Eur Respiratory Soc
Cases of COVID-19 associated pulmonary aspergillosis (CAPA) are being increasingly
reported and physicians treating patients with COVID-19-related lung disease need to …

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European …

…, PLWhite,GH Goldman,PBowyer… - 临床微生物学…,2022年 - Elsevier
Objectives Coronavirus disease 2019 (COVID-19) -associated pulmonary aspergillosis (CAPA)
has emerged as a complication in critically ill COVID-19 patients. The objectives of this …

AspergillusPolymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing

plWhite,JR Wingard, S Bretagne… - Clinical Infectious …, 2015 - academic.oup.com
Background. Aspergillus polymerase chain reaction (PCR) was excluded from the
European Organisation for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/…

Evaluation of Aspergillus PCR protocols for testing serum specimens

plWhite, C Mengoli, S Bretagne… - Journal of clinical …, 2011 - Am Soc Microbiol
A panel of human serum samples spiked with various amounts of Aspergillus fumigatus
基因组DNA分布在欧洲曲霉PCR倡议中的23个中心。